The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts."
<iframe src="https://statesidedaily.com/embed/cluster/59a9938cfe99658b3b50e1df3f4ef165ca37370f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Will an FDA crackdown curb access to cheaper GLP-1 weight-loss drugs?"></iframe>
The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts."